clinical trial

[Tiziana Life Sciences Ltd.] Tiziana Life Sciences announced initiation of a Phase Ib clinical trial to evaluate orally administered enteric-coated capsules of foralumab in patients with mild-to-moderate Crohn's Disease.

[Lung Therapeutics, Inc] Lung Therapeutics, Inc. announced the successful completion of a Phase Ia clinical trial for LTI-03, a Caveolin-1-related peptide designed to treat idiopathic pulmonary fibrosis.

[IMAC Holdings, Inc. (] IMAC Holdings, Inc. announced it has initiated the third and final cohort of its Phase I clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease.

[Ossium Health, Inc. (Business Wire, Inc.)] Ossium Health, Inc. announced that the US FDA has accepted its Investigational New Drug application for OSSM-001, an MSC product, for the treatment of refractory perianal fistulas in patients with Crohn’s disease.

[Oryzon Genomics, S.A.] Oryzon Genomics, S.A. announced that it has received notification from the US FDA that its Investigational New Drug application (IND) for iadademstat is now approved to initiate a Phase Ib clinical trial in patients with relapsed/refractory AML harboring a FMS-like tyrosine kinase mutation (FLT3mut+ ).

[Enochian BioSciences] Enochian BioSciences issued an exclusive sub-license of one of its proprietary technologies that could improve the effectiveness of a potential cure for HIV with an anti-HIV CAR-T therapy that Caring Cross is studying in a clinical trial.